@article {e000891corr1, editor = {,}, title = {Correction: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial}, volume = {9}, number = {5}, elocation-id = {e000891corr1}, year = {2021}, doi = {10.1136/jitc-2020-000891corr1}, publisher = {BMJ Specialist Journals}, URL = {https://jitc.bmj.com/content/9/5/e000891corr1}, eprint = {https://jitc.bmj.com/content/9/5/e000891corr1.full.pdf}, journal = {Journal for ImmunoTherapy of Cancer} }